Dornase alfa in premature infants with severe respiratory distress and early bronchopulmonary dysplasia

Journal of Perinatology

Volumn 20, Issue 8 PART. 1, 2000, Pages 530-534

  Reiter, Pamela D ^a   Townsend, Susan F ^a   Velasquez, Rachelle ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; DNASE1 PROTEIN, HUMAN; EXPECTORANT AGENT; RECOMBINANT PROTEIN;

ARTICLE; CASE REPORT; FEMALE; HUMAN; LUNG DYSPLASIA; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PREMATURITY; RETROSPECTIVE STUDY;

BRONCHOPULMONARY DYSPLASIA; DEOXYRIBONUCLEASE I; EXPECTORANTS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; RECOMBINANT PROTEINS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETROSPECTIVE STUDIES;

EID: 0034572521     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7200456     Document Type: Article

References (24)

1. Farrell PA, Fiascone JM. Bronchopulmonary dysplasia in the 1990s: a review for the pediatrician. Curr Probl Pediatr 1997;27:129-63.
2. Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995;126:605-10.
3. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins LM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988;82:527-32.
4. Farrell PA, Fiascone JM. Strategies for the prevention of bronchopulmonary dysplasia and chronic lung disease of infancy in the 1990s. Neonat Respir Dis 1998;8:1-10.
5. Taghizadeh A, Reynolds EO. Pathogenesis of bronchopulmonary dysplasia following hyaline membrane disease. Am J Pathol 1976;82:241-64.
6. Gerstmann DR, Minton SD, Stoddard RA, et al. The Provo multicenter early high-frequency oscillatory ventilation trial: improved pulmonary and clinical outcome in respiratory distress syndrome. Pediatrics 1996;98:1044-57.
7. Sims ME, Rangasamy R, Lee S, Chung H, Cohen J, Walther FJ. Comparative evaluation of caffeine and theophylline for weaning premature infants from the ventilator. Am J Perinatol 1989;6:72-5.
8. Barrington KJ, Finer NN. Treatment of bronchopulmonary dysplasia: a review. Clin Perinatol 1988;25:177-202.
9. Hubbard RC, McElvaney NG, Birrer P, et al. A preliminary study of aerosolized recombinant human deoxyribonudease I in the treatment of cystic fibrosis. N Engl J Med 1992;326:812-15.
10. Ranasinha C, Assoufi B, Shak S, et al. Efficacy and safely of short-term administration of aerosolized recombinant human DNase (rhDNase) in adults with stable stage cystic fibrosis. Lancet 1993;342:199-202.
11. Ramsey BW, Astley SW, Aitken MI, et al. Efficacy and safety of short-term administration of aerosolized recombinant human DNase (rhDNase) in patients with cystic fibrosis. Am Rev Respir Dis 1993;148:145-51.
12. Aitken ML, Burke W, McDonald G, et al. Recombinant human DNase inhaled in normal subjects and patients with cystic fibrosis. JAMA 1992;267;1947-51.
13. Fuchs HG, Borowitz DS, Christensen DH, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med 1994; 331:637-42.
14. Shah PL, Scott SF, Hodson ME. Report on a multi-centre study using aerosolized recombinant human DNase I in the treatment of cystic fibrosis patients with severe pulmonary disease [abstract]. Pediatr Pulmonol 1993;Suppl 9:157.
15. McCoy, K Hamilton S, Johnson C. Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Chest 1996;110:889-95.
16. Kling S, Gie RP, Riphagen S. Domase alpha in the management of a mechanically ventilated infant with q'stic fibrosis [letter]. Pediatr Pulmonol 1997;24(2):124-5.
17. Fernandez R, Sole J, Blanch L, Artigas A. The effect of short-term instillation of a mucolytic agent (mesna) on airway resistance in mechanically ventilated patients. Chest 1995;107:1101-06.
18. Zandstra DF, Stoutenbeek CP, Miranda DR. Effect of mucolytic and bronchodilator aerosol therapy on airway resistance in mechanically ventilated patients. Int Care Med 1985;11:16-18.
19. Bibi H, Seifert B, Oullette M, Belik J. Intratracheal N-acetylcysteine use in infants with chronic lung disease. Acta Paediatr 1992;81(4):335-9.
20. Henke CA, Hertz M, Gustafson P. Combined bronchoscopy and mucolytic therapy for patients with severe refractory status asthmaticus on mechanical ventilation: a case report and review of the literature. Crit Care Med 1994;22(11):1880-83.
21. Maayan C, Bar-Yishay E, Yaacobi T, et al. Immediate effect of various treatments on lung function in infants with cystic fibrosis. Respiration 1989;55(3):144-51.
22. Bhandari V, Hussain N, Rosenkrantz T, Kresch M. Respiratory tract colonization with mycoplasma species increase the severity of bronchopulmonary dysplasia. J Perinatol Med 1998;26(1):37-42.
23. Able-Horn M, Genzel-Boroviczeny O, Uhlig T, Zimmermann A, Peters J, Scholz M. Ureaplasma urealyticum colonization and bronchopulmonary dysplasia: a comparative prospective multicentre study. Eur J Pediatr 1998;157(12):1004-11.
24. Cordero L, Ayers LW, Davis K. Neonatal airway colonization with gram-negative bacilli: association with severity of bronchopulmonary dysplasia. Pediatr Infect Dis J 1997;16(1):18-23.